Cytomegalovirus (CMV) infection has been associated with poor outcomes after liver transplantation. Whether it is safe to perform transplantation for patients with active CMV viremia is not known. Here we report the outcomes of 6 patients with CMV viremia immediately before or at the time of liver transplantation. Data from these patients indicate that CMV can be adequately controlled with antiviral therapy, although patients appear to be at higher risk for indirect effects of CMV such as other opportunistic infections and liver allograft dysfunction.
ASJC Scopus subject areas